Grifols (GRFS) EBT Margin (2010 - 2020)
Grifols (GRFS) posted EBT Margin of 19.43% for Q1 2020, up 30.14% quarter-over-quarter from 14.93% in Q4 2019, and up 708.0% year-on-year from 2.4% in Q2 2019.
Grifols (GRFS) EBT Margin (2010 - 2020) Analysis & Trends
Grifols (GRFS) has reported EBT Margin for 10 consecutive years, with 19.43% the latest figure, recorded in Q1 2020.
- EBT Margin for Q1 2020 came in at 19.43%, up 708.0% year-over-year; the trailing twelve-month figure through Mar 2020 was 16.26% (down 96.0% YoY), and the FY2025 annual result was 8.17%, down 22201.0% from the prior year.
- EBT Margin was 19.43% for Q1 2020 at Grifols, up from 14.93% in the prior quarter.
- Over five years, EBT Margin peaked at 36.05% in Q1 2016 and troughed at 9.78% in Q4 2016.
- Average EBT Margin over 5 years is 18.05%, with a median of 17.49% recorded in 2018.
- Year-over-year, EBT Margin jumped 1824 bps in 2016 and sank 1880 bps in 2017.
- Over 5 years, EBT Margin stood at 9.78% in 2016, then soared by 86 bps to 18.15% in 2017, then retreated by 1 bps to 17.92% in 2018, then dropped by 17 bps to 14.93% in 2019, then soared by 30 bps to 19.43% in 2020.
- Per Business Quant data, the three most recent EBT Margin figures were 19.43% in Q1 2020, 14.93% in Q4 2019, and 12.35% in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 44.70% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 24.89% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 6.93% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 27.21% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -21.49% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 24.18% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 37.07% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 135.53% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 19.43% |
| Dec 31, 2019 | 14.93% |
| Mar 31, 2019 | 12.35% |
| Dec 31, 2018 | 17.92% |
| Sep 30, 2018 | 41.06% |
| Jun 30, 2018 | 19.91% |
| Mar 31, 2018 | 17.49% |
| Dec 31, 2017 | 18.15% |
| Jun 30, 2017 | 17.40% |
| Mar 31, 2017 | 17.26% |
| Dec 31, 2016 | 9.78% |
| Sep 30, 2016 | 17.67% |
| Jun 30, 2016 | 16.36% |
| Mar 31, 2016 | 36.05% |
| Dec 31, 2015 | 16.32% |
| Sep 30, 2015 | 18.81% |
| Jun 30, 2015 | 0.02% |
| Mar 31, 2015 | 17.81% |
| Dec 31, 2014 | -17.45% |
| Sep 30, 2014 | 16.48% |